CAL
CL icon

Capital Analysts LLC’s Colgate-Palmolive CL Stock Holding History

Capital Analysts LLC’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12K Buy
145
+6
+4% +$535 ﹤0.01% 1219
2025
Q4 		$11K Sell
139
-125
-47% -$9.8K ﹤0.01% 1223
2025
Q3 		$21K Hold
264
– – ﹤0.01% 1063
2025
Q2 		$24K Sell
264
-138
-34% -$12.6K ﹤0.01% 972
2025
Q1 		$38K Sell
402
-137
-25% -$12.3K ﹤0.01% 851
2024
Q4 		$49K Sell
539
-27
-5% -$2.58K ﹤0.01% 750
2024
Q3 		$59K Hold
566
– – ﹤0.01% 684
2024
Q2 		$55K Sell
566
-173
-23% -$16K ﹤0.01% 688
2024
Q1 		$67K Buy
739
+1
+0.1% +$85 ﹤0.01% 602
2023
Q4 		$59K Sell
738
-38
-5% -$2.86K ﹤0.01% 620
2023
Q3 		$55K Buy
776
+36
+5% +$2.69K ﹤0.01% 588
2023
Q2 		$57K Sell
740
-116
-14% -$8.98K ﹤0.01% 556
2023
Q1 		$64K Buy
856
+30
+4% +$2.23K ﹤0.01% 546
2022
Q4 		$65K Sell
826
-3,224
-80% -$242K ﹤0.01% 574
2022
Q3 		$284K Buy
4,050
+28
+0.7% +$2.2K 0.02% 323
2022
Q2 		$322K Buy
4,022
+20
+0.5% +$1.56K 0.02% 298
2022
Q1 		$303K Buy
4,002
+227
+6% +$18K 0.02% 305
2021
Q4 		$322K Buy
3,775
+45
+1% +$3.51K 0.02% 302
2021
Q3 		$282K Sell
3,730
-475
-11% -$37.7K 0.02% 306
2021
Q2 		$342K Buy
4,205
+19
+0.5% +$1.55K 0.02% 286
2021
Q1 		$330K Buy
4,186
+3,033
+263% +$238K 0.02% 285
2020
Q4 		$99K Buy
1,153
+2
+0.2% +$165 0.01% 313
2020
Q3 		$89K Buy
1,151
+2
+0.2% +$152 0.01% 328
2020
Q2 		$84K Buy
1,149
+3
+0.3% +$213 0.01% 293
2020
Q1 		$76K Buy
1,146
+2
+0.2% +$141 0.01% 285
2019
Q4 		$79K Buy
1,144
+2
+0.2% +$136 0.01% 334
2019
Q3 		$83K Buy
1,142
+849
+290% +$61.6K 0.01% 306
2019
Q2 		$21K Buy
+293
New +$20.8K ﹤0.01% 454
2017
Q4 		– Sell
-123
Closed -$9K – 449
2017
Q3 		$9K Buy
+123
New +$8.87K ﹤0.01% 390

Other funds holding CL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Capital Analysts LLC's CL Position: Q1 2026 in Review

Capital Analysts LLC increased its Colgate-Palmolive (CL) stake by 4.3% in Q1 2026, buying an estimated $535 and bringing the position to 145 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #1219.

Capital Analysts LLC first reported a position in CL in Q3 2017 and has held it in 29 quarters since. The position peaked at $342K in Q2 2021. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Capital Analysts LLC held 145 shares of Colgate-Palmolive worth $12K as of Q1 2026.
  • Capital Analysts LLC bought 6 Colgate-Palmolive shares in Q1 2026, an estimated $535.
  • Colgate-Palmolive made up ﹤0.01% of Capital Analysts LLC's portfolio in Q1 2026, its #1219 holding.
  • Capital Analysts LLC first reported a position in Colgate-Palmolive in Q3 2017 and has held it in 29 quarters since.
  • Capital Analysts LLC's Colgate-Palmolive position peaked at $342K in Q2 2021.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Capital Analysts LLC's 13F filing for Q1 2026, filed 14 May 2026.